Patient safety & QA quiz
Updated
Patient Safety & Quality Assurance is 23.75% of the 2026 PTCE — about 19 of the 80 scored questions. Every rationale names the safety principle behind the answer.
Question 1 of 25
0 answered · 0 flagged
After most routine vaccinations, how long does CDC guidance suggest patients be observed in the pharmacy?
The safety tables worth memorizing
The cheat tables behind the questions — open what you missed, then drill again.
Look-alike / sound-alike pairs (Tall Man)
| Pair | Why it's dangerous | |
|---|---|---|
| hydrOXYzine | hydrALAZINE | antihistamine vs antihypertensive |
| predniSONE | prednisoLONE | different potency — not interchangeable mg-for-mg |
| glipiZIDE | glyBURIDE | both sulfonylureas — different durations, hypoglycemia risk |
| buPROPion | busPIRone | antidepressant vs anxiolytic |
| DOPamine | DOBUTamine | different hemodynamic effects |
| ALPRAZolam | LORazepam | benzodiazepine pair — dosing differs |
| carBAMazepine | OXcarbazepine | related anticonvulsants, different doses |
| vinBLAStine | vinCRIStine | chemotherapy pair — mix-ups have been fatal |
| cefTRIAXone | ceFAZolin | different-generation cephalosporins |
| chlorproMAZINE | chlordiazePOXIDE | antipsychotic vs benzodiazepine |
Source: FDA and ISMP — look-alike drug names with recommended tall man letters (ISMP resource, ECRI-hosted) · verified 2026-08-03
High-alert medication classes
| Class | Why it's high-alert |
|---|---|
| Insulin (all formulations) | Unit/concentration confusion; U-100 vs U-500; never abbreviate "U" |
| Anticoagulants (heparin, warfarin, DOACs) | Narrow margin — bleeding; heparin concentration mix-ups |
| Opioids | Respiratory depression; patch strengths; look-alike names |
| Concentrated electrolytes (KCl injection) | Fatal if given undiluted — stored away from floor stock |
| Chemotherapeutic agents | Low therapeutic index; weekly-vs-daily errors (oral methotrexate) |
| Neuromuscular blocking agents | Paralyze breathing — catastrophic outside ventilated patients |
| Moderate sedation agents | Airway compromise risk outside monitored settings |
| Epidural / intrathecal medications | Route errors are frequently fatal |
Source: ISMP — list of high-alert medications in acute care settings (2024) · verified 2026-08-03
Error-reporting programs
| Program | Run by | What to report |
|---|---|---|
| MedWatch | FDA | Serious adverse events, product quality problems, therapeutic failures |
| VAERS | CDC + FDA | Adverse events after vaccination |
| ISMP MERP | ISMP (voluntary, confidential) | Medication errors and near misses, to drive system fixes |
Source: FDA MedWatch · verified 2026-08-03
Common questions
How many patient safety questions are on the PTCE?
Patient Safety & Quality Assurance is 23.75% of the exam — about 19 of the 80 scored questions, the second-largest domain on the 2026 outline. It rewards knowing the error-prevention systems, not memorizing trivia.
What is a high-alert medication?
A drug that causes serious patient harm when misused — insulin, anticoagulants, opioids, concentrated electrolytes, chemotherapy. The point tested is the heightened process around them: separated storage, double checks, and standardized concentrations, per the ISMP high-alert list.
What are LASA drugs and Tall Man lettering?
Look-alike/sound-alike (LASA) drugs are name pairs that get confused — hydrOXYzine and hydrALAZINE. Tall Man lettering capitalizes the differing letter blocks so the eye catches the difference on shelves and screens. The FDA/ISMP list below shows the tested pairs.
Where do you report medication errors?
Serious adverse events and product problems go to FDA MedWatch; vaccine reactions go to VAERS; and practitioners voluntarily report errors and near misses to ISMP’s MERP, which drives system-level fixes. Knowing which program handles which report is a reliable exam point.